CXCR3 and sarcoidosis: Next, we noticed that the relative number of CXCR3-expressing cells within EM Tregs were augmented in patients with sarcoidosis vs. the control group (46.47% (40.00; 55.01) vs. 34.53% (29.24; 38.97) with p < 0.01).